Form 13G Boundless Bio For: 4 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Boundless Bio Inc (BOLD)
Assess today's live Boundless Bio Inc (BOLD) share price, performance and insights using our live NASDAQ: BOLD stock exchange data.
Analyse the historical data and Boundless Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Boundless Bio share price buy/sell indicators using real-time data (or discuss the Boundless Bio (BOLD) stock price today with other investors in the Boundless Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BOLD share price (ISIN: US10170A1007) to enhance your trading decisions with our free investment tools and resources.
What Is the Boundless Bio Inc Share Price Today?
The Boundless Bio share price today is 1.21.
What Is the Stock Symbol for Boundless Bio Inc
The stock symbol (or 'ticker') for Boundless Bio Inc is "BOLD."
What Stock Exchange Does Boundless Bio Inc Trade On?
Boundless Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Boundless Bio Inc a Good Stock to Buy?
Determining whether Boundless Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Boundless Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Boundless Bio share price buy/sell indicators using real-time data (or discuss the Boundless Bio (BOLD) stock price today with other investors in the Boundless Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BOLD share price (ISIN: US10170A1007) to enhance your trading decisions with our free investment tools and resources.
What Is the Boundless Bio Inc Share Price Today?
The Boundless Bio share price today is 1.21.
What Is the Stock Symbol for Boundless Bio Inc
The stock symbol (or 'ticker') for Boundless Bio Inc is "BOLD."
What Stock Exchange Does Boundless Bio Inc Trade On?
Boundless Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Boundless Bio Inc a Good Stock to Buy?
Determining whether Boundless Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.17
1.28
52 wk Range
1.00
3.12
Unusual Post-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.171.28
52 wk Range
1.003.12
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BOLD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
3.00
Upside
+147.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Boundless Bio Inc For: 5 November
- Investing.com
- Form 13G Boundless Bio For: 4 December
- Investing.com
- Form 8K Boundless Bio Inc For: 5 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Boundless Bio Company Profile
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company’s lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Compare BOLD to Peers and Sector
Metrics to compare | BOLD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBOLDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −7.9x | −0.6x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 0.2x | 1.6x | 2.6x | |
Price / LTM Sales | - | 27.5x | 3.2x | |
Upside (Analyst Target) | 143.9% | 47.3% | 41.8% | |
Fair Value Upside | Unlock | 0.9% | 5.1% | Unlock |
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.00
(+147.93% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.62 / -1.09
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Boundless Bio (BOLD) Share Price Today?
The live Boundless Bio share price today is 1.21
What Stock Exchange Does Boundless Bio (BOLD) Trade On?
Boundless Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Boundless Bio?
The stock symbol (also called a 'ticker') for Boundless Bio is "BOLD."
What Is the Current Boundless Bio Market Cap?
As of today, Boundless Bio market capitalisation is 27.08M.
What Is Boundless Bio's (BOLD) Earnings Per Share (TTM)?
The Boundless Bio EPS is currently -2.76 (Trailing Twelve Months).
When Is the Next Boundless Bio Earnings Date?
Boundless Bio's next earnings report will be released on 05 Nov 2025.
Is BOLD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Boundless Bio moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Boundless Bio Stock Split?
Boundless Bio has split 0 times. (See the BOLD stock split history page for full effective split date and price information.)
How Many Employees Does Boundless Bio Have?
Boundless Bio has 64 employees.
What is the current trading status of Boundless Bio (BOLD)?
As of 24 Dec 2025, Boundless Bio (BOLD) is trading at a price of 1.21, with a previous close of 1.23. The stock has fluctuated within a day range of 1.17 to 1.28, while its 52-week range spans from 1.00 to 3.12.
What Is Boundless Bio (BOLD) Price Target According to Analysts?
The average 12-month price target for Boundless Bio is USD3, with a high estimate of USD3 and a low estimate of USD3. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +147.93% Upside potential.
What Is the BOLD Premarket Price?
BOLD's last pre-market stock price is 1.28. The pre-market share volume is 2,350.00, and the stock has decreased by 0.05, or 4.07%.
What Is the BOLD After Hours Price?
BOLD's last after hours stock price is 1.29, the stock has decreased by 0.08, or 6.53%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.